Lab Information

Madhukar Pai (MD/PhD)

Senior Scientist
Centre for Outcomes Research and Evaluation
Department of Epidemiology, Biostatistics and Occupational Health (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 0%
 Epidemiology: 100%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 https://www.paitbgroup.org/

Keywords

Tuberculosis • diagnostics • epidemiology • global health • implementation research

Research Interests

My research focuses on tuberculosis. It is a major threat to human health, with 9 million new cases and 1.5 million deaths every year. I have focused my career on improving tuberculosis diagnosis and care, with research that includes evaluating diagnostics tests that could eventually be part of country-level policies, implementation of tools and policies, and improving tuberculosis care for vulnerable populations in different countries worldwide. For example, I have compared the accuracy and usefulness of new tests that can diagnose tuberculosis in a few hours to conventional techniques which may require days before results are known. I am also conducting a study using mystery patients to evaluate the quality of tuberculosis care offered by health providers in India. The overall goal of my research program is to use translational epidemiology and implementation science to support tuberculosis care and control, so that the products developed, knowledge and policies can translate into saved lives.


Team Members

Name Position

Latest Publications

  1. Bhatia, V., Rijal, S., Sharma, M., Islam, A., Vassall, A., Bhargava, A., Thida, A., Basri, C., Onozaki, I., Pai, M., Rezwan, M. K., Arinaminpathy, N., Chandrashekhar, P., Sarin, R., Mandal, S. & Raviglione, M. (2023). Ending TB in South-East Asia: flagship priority and response transformation. The Lancet regional health. Southeast Asia, vol. 18, p. 100301.
  2. Bigio, J., MacLean, E.-L., Das, R., Sulis, G., Kohli, M., Berhane, S., Dinnes, J., Deeks, J. J., Brümmer, L. E., Denkinger, C. M. & Pai, M. (2023). Accuracy of package inserts of SARS-CoV-2 rapid antigen tests: a secondary analysis of manufacturer versus systematic review data. The Lancet. Microbe, vol. 4, p. e875-e882.
  3. Anand, S. S. & Pai, M. (2023). Glocal is global: reimagining the training of global health students in high-income countries. The Lancet. Global health, vol. 11, p. e1686-e1687.
  4. Reid, M., Agbassi, Y. J. P., Arinaminpathy, N., Bercasio, A., Bhargava, A., Bhargava, M., Bloom, A., Cattamanchi, A., Chaisson, R., Chin, D., Churchyard, G., Cox, H., Denkinger, C. M., Ditiu, L., Dowdy, D., Dybul, M., Fauci, A., Fedaku, E., Gidado, M., Harrington, M., Hauser, J., Heitkamp, P., Herbert, N., Herna Sari, A., Hopewell, P., Kendall, E., Khan, A., Kim, A., Koek, I., Kondratyuk, S., Krishnan, N., Ku, C.-C., Lessem, E., McConnell, E. V., Nahid, P., Oliver, M., Pai, M., Raviglione, M., Ryckman, T., Schäferhoff, M., Silva, S., Small, P., Stallworthy, G., Temesgen, Z., van Weezenbeek, K., Vassall, A., Velásquez, G. E., Venkatesan, N., Yamey, G., Zimmerman, A., Jamison, D., Swaminathan, S. & Goosby, E. (2023). Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis. Lancet (London, England), vol. 402, p. 1473-1498.
  5. Faust, L., Naidoo, P., Caceres-Cardenas, G., Ugarte-Gil, C., Muyoyeta, M., Kerkhoff, A. D., Nagarajan, K., Satyanarayana, S., Rakotosamimanana, N., Grandjean Lapierre, S., Adejumo, O. A., Kuye, J., Oga-Omenka, C., Pai, M. & Subbaraman, R. (2023). Improving measurement of tuberculosis care cascades to enhance people-centred care. The Lancet. Infectious diseases, vol. 23, p. e547-e557.
  6. Bhargava, A., Bhargava, M., Meher, A., Benedetti, A., Velayutham, B., Sai Teja, G., Watson, B., Barik, G., Pathak, R. R., Prasad, R., Dayal, R., Madhukeshwar, A. K., Chadha, V., Pai, M., Joshi, R., Menzies, D. & Swaminathan, S. (2023). Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial. Lancet (London, England), vol. 402, p. 627-640.
  7. Branigan, D., Denkinger, C. M., Furin, J., Heitkamp, P., Deborggraeve, S., van Gemert, W., Herrera, R., Kondratyuk, S., McKenna, L., Ndjeka, N., Omar, S. V. & Pai, M. (2023). Diagnostics to support the scaling up of shorter, safer tuberculosis regimens. The Lancet. Microbe, vol. 4, p. e758-e760.
  8. Houston, A. R., Liu, J., Habibi, R., Murthy, S. & Pai, M. (2023). Canada's role in covid-19 global vaccine equity failures. BMJ (Clinical research ed.), vol. 382, p. e075149.
  9. Bigio, J., Hannay, E., Pai, M., Alisjahbana, B., Das, R., Huynh, H. B., Khan, U., Mortera, L., Nguyen, T. A., Safdar, M. A., Shrestha, S., Venkat Raman, A., Verma, S. C., Yellappa, V. & Srivastava, D. (2023). The inclusion of diagnostics in national health insurance schemes in Cambodia, India, Indonesia, Nepal, Pakistan, Philippines and Viet Nam. BMJ global health, vol. 8.
  10. Miller, R., Wafula, F., Eman, K. U., Rakesh, P. S., Faleye, B. O., Duggan, C., Sousa Pinto, G., Heitkamp, P., Rana, N., Klinton, J. S., Sulis, G., Oga-Omenka, C. & Pai, M. (2023). Pharmacy engagement in TB prevention and care: not if, but how?. BMJ global health, vol. 8.
More on PubMed 



See also

Card image
Nandini
Dendukuri


See profile